BACKGROUND: Cancer remains a significant global health challenge. Several plant-derived compounds have garnered the attention of cancer research for their anticancer effects. Chickpea (Cicer arietinum) is one of the top nutritious legumes with promising chemoprotective effects. We previously demonstrated that Cicer arietinum extract (CAE) has antitumor activity in vitro. Therefore, herein, we aimed to extend our findings and investigate CAE's preventive and therapeutic antitumor effects in vivo using a murine Ehrlich solid carcinoma (ESC) model. METHODS: Thirty-six female mice were divided into six groups: healthy controls, untreated ESC-bearing mice, CAE pre-treated groups (low, moderate, and high doses), and CAE post-treated group administered after tumor establishment. Tumor size, oxidative stress markers, antioxidant enzyme activities, and the expression of apoptotic (Casp3)- and pyroptotic (Gsdmd)-related genes were assessed. Finally, the immunohistochemical staining for the anti-apoptotic Survivin expression was assessed across different mice groups. RESULTS: Our data indicate that pre-treatment with moderate and high doses of CAE, as well as post-treatment, significantly inhibited tumor growth by more than 40% relative to untreated ESC-bearing controls. Histopathological analysis showed notable improvements in muscle tissue structure in CAE-treated samples. Mechanistically, CAE exerted its chemopreventive and therapeutic effects via the alleviation of oxidative stress by a significant enhancement of the antioxidant enzyme activities and increased Gpx4 mRNA expression, accompanied by a reduction of MDA and NO levels. Furthermore, CAE attenuated survivin expression, while dramatically boosting the expression of apoptotic Casp3 and pyroptotic Gsdmd markers, particularly in the post-treatment group. CONCLUSION: These findings suggest that CAE is a promising anticancer agent with protective effects against ESC.
Cicer arietinum extract as antitumor and protective agent against Ehrlich Solid Carcinoma-bearing mice.
鹰嘴豆提取物作为抗肿瘤剂和保护剂对抗荷艾氏实体癌小鼠
阅读:8
作者:Sayed Amany Ahmed, Abdullah Mahmoud Salah, WalyEldeen Amr Ahmed, Sayed Rasha Mohamed Samir, Gabre Refaat M, Ibrahim Sherif Abdelaziz, Hassan Hebatallah
| 期刊: | BMC Complementary and Alternative Medicine | 影响因子: | 3.400 |
| 时间: | 2025 | 起止号: | 2025 Sep 2; 25(1):325 |
| doi: | 10.1186/s12906-025-05061-z | 研究方向: | 肿瘤 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
